AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05151432 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Pulsed Ultrasound
Description: Active US therapy will be administered using a device 4cm², 1- MHz US with a sound-head area of effective 4cm, radiating area of 3.5 to a beam non-uniformity ratio of cm². 5:1, and a therapeutic dose of approximately 112.5J/ That is, the pulsed US will be delivered for 9.5 minutes with a peak intensity of 1W/cm² at a 20% duty cycle, to achieve a spatial-temporal average intensity of 0.2W
Study NCT05151432 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Pulsed Electromagnetic field
Description: The patient's knee will be placed between 2 plates coil applicator generating a magnetic field intensity of 1.5 mT and a frequency of 75Hz.
Study NCT05151432 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Traditional exercise program
Description: Stretching exercises, Isometric quadriceps exercise, Straight leg raising (SLR) exercise, Isometric hip adduction exercise, Hip abductor strengthening, Hip extensor strengthening, Hip external rotator strengthening
Study NCT05151432 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sham Pulsed US & Electromagnetic field
Description: The patients will receive Sham Pulsed US \& Electromagnetic field.
Study NCT04899440 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Water Flosser
Description: A pressurized stream of water to reduce gingivitis and remove adherent plaque
Study NCT04899440 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Control
Description: No Oral Irrigator Control
Study NCT01320761 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ATX-101-BA-free
Description: ATX-101-BA-free
Study NCT01320761 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ATX-101-BA
Description: ATX-101-BA
Study NCT06415994 — intervention group
Intervention type: OTHER
Intervention: Blood and Placental Samples
Description: At each MRI visit a blood sample will be collected for substances, DNA, RNA, epigenetics, and placental biomarkers.~At delivery: A sample of placenta will be collected for RNA, DNA, and epigenetic analysis.
Study NCT05035563 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intervention. Early and integral communication strategy (EICS)
Description: This intervention will be implemented in patients since they are hospitalized in the ICU where is expected:~* Facilitate contact and communication between patients, families and the health team.~* Respond to the communication needs of family members.~* Reduce equipment overload and facilitate communication with families and patients, providing tools and timely support.~* Build a positive and trusting relationship of relatives and patients with health teams.~The intervention considers the following actions:~1. - Training in communication to the health team~2. - Written material~3. - Family website~4. - Standardized and daily telephone information~5. - Health Team Support Strategy~6. - Weekly multidisciplinary virtual meeting with the family~7. - ICU diaries for family members
Study NCT05030415 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ixekizumab Auto-Injector
Description: 160 mg week 0 followed by 80 mg every two weeks
Study NCT05085704 — intervention group
Intervention type: DEVICE
Intervention: Magnetic resonance imaging
Description: Medical imaging technique used in radiology to form pictures of the anatomy.
Study NCT05401695 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: HA330 hemoadsorption technique
Description: Hemoadsorption (HA) treatment An HA330 disposable hemoperfusion cartridge (HA330; Jafron, Zhuhai City, China) was used with a continuous renal replacement therapy (CRRT) machine (Aquarius® or Primaflex®) in the intervention group. We will select a blood circuit for each machine according to the patient's body weight. Vascular access will be established with ultrasound-guided insertion of a double-lumen venous catheter into the right internal jugular or femoral vein. HA will be performed for a maximum of 4 hours, and the second session will be started approximately 24 hours after the end of the first session. The blood flow rate will be started low and be gradually increased while monitoring real-time blood pressure and vital signs with an arterial-line monitor. After the end of the HA session, CRRT will be continued if required.
Study NCT06481228 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: CAR-T cells
Description: CAR-T cells as consolidation therapy
Study NCT06481228 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Venetoclax
Description: BCL2 inhibitor
Study NCT06481228 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Olverembatinib
Description: TKI
Study NCT06261736 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotics
Description: These participants will be given a single dose of an oral antibiotic prior to the procedure.
Study NCT06261736 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: No antibiotics
Description: These participants will not be given an antibiotic prior to the procedure.
Study NCT05581082 — intervention group
Intervention type: OTHER
Intervention: Pragmatic, exploratory study of Precision Medicine
Description: This pragmatic, exploratory study consists of individuals with frailty who are referred from routine care to a physical therapy-based strengthening intervention. This specific study will collect ancillary measures to evaluate our outcomes. The study staff will not be conducting any interventions themselves - the physical therapy program is as per usual care.
Study NCT05087927 — intervention group
Intervention type: BEHAVIORAL
Intervention: Gain framing plus demographically targeted photos
Description: Gain framing: Participant feels PrEP puts her in control~Participants (majority of whom will be African American) will be shown an image of women of multiple races.
Study NCT05087927 — intervention group
Intervention type: BEHAVIORAL
Intervention: Loss framing plus demographically targeted photos
Description: Loss framing: Without PrEP, participant feels less in control~Participants (majority of whom will be African American) will be shown an image of women of multiple races.
Study NCT05087927 — intervention group
Intervention type: BEHAVIORAL
Intervention: Gain framing plus not demographically targeted photos
Description: Gain framing: Participant feels PrEP puts her in control~Participants (majority of whom will be African American) will be shown an image of an African American woman.
Study NCT05087927 — intervention group
Intervention type: BEHAVIORAL
Intervention: Loss framing plus not demographically targeted photos
Description: Loss framing: Without PrEP, participant feels less in control~Participants (majority of whom will be African American) will be shown an image of an African American woman.
Study NCT06067685 — intervention group
Intervention type: OTHER
Intervention: Observation
Description: Prospective Observation only. Will record serum triglyceride, fingerstick blood triglyceride measurements, cord c-peptide, and neonatal body fat composition measurements in the first 6 months.
Study NCT05988294 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pilates exercises
Description: One-hour Pilates exercise program was given by a certified trainer to patients three times per week for 12 weeks. The exercise program followed the basic principles of the Pilates method. Our protocol comprised the following components of Pilates-based exercises: strength and stabilization, flexibility and range of motion, proper body alignment, balance, coordination, and body awareness. Resistance bands and 26 cm Pilates balls were used as supportive equipment. The exercise sections consisted of 5 minutes breathing, 10 minutes warm-up, 35 minutes conditioning phase and 10 minutes cool-down.
Study NCT05988294 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional physical therapy exercise program
Description: Diaphragmatic deep breathing exercises, bronchial hygiene techniques, assisted cough, stretching exercises and ROM exercises for both upper and lower limbs for 45 minutes, 3 days/ week for 12 weeks.
Study NCT06251050 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: lithium-containing mouthwash
Description: The main ingredients of lithium-containing mouthwash are lithium carbonate and citric acid. A total of 5 concentration gradients of lithium-containing mouthwash are set, including 0.03, 0.06, 0.10, 0.15 and 0.21 mol/L. Mouthwash is used to gargle and left in the mouth for 5 min to be spat out three times a day from the first day of radiotherapy up to the end of treatment.
Study NCT06251050 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Plcacebo mouthwash
Description: Placebo Mouthwash is mainly composed of citric acid and sodium hydroxide, transparent colorless liquid. Mouthwash is used to gargle and left in the mouth for 5 min to be spat out three times a day from the first day of radiotherapy up to the end of treatment.
Study NCT06251050 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: lithium-containing mouthwash
Description: Effective lithium salt concentrations screened in the Phase I trial is used as active interventions in this group of interventions. Mouthwash is used to gargle and left in the mouth for 5 min to be spat out three times a day from the first day of radiotherapy up to the end of treatment.
Study NCT05988294 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Conventional physical therapy exercise program
Description: Diaphragmatic deep breathing exercises, bronchial hygiene techniques, assisted cough, stretching exercises and ROM exercises for both upper and lower limbs for 45 minutes, 3 days/ week for 12 weeks.
Study NCT05948267 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ketamine- dexmeditomidine admixure
Description: ketamine in anesthetic dose mixed with two different doses of dexmeditomidine
Study NCT05948267 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Propofol, Lidocaine and fentanyl
Description: Propofol (2mg/kg) prepared as will be mixed with 2 mL Lidocaine (40 mg) for concentration 10mg/ml and fentanyl (1mic/kg) prepared for concentration 10mg/ml
Study NCT06541054 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: WARM SOCKS
Description: One hour before the operation,warm socks will be put on the experimental group,body temperature,heart rate,blood pressure,SPO2 will be measured and recorded every fifteen minutes.During the surgery,body temperature,heart rate,blood pressure,SPO2 value, drainage amount will be measured and recorded every fifteen minutes.The patient will be transferred to the postoperative care unit with warm socks and will stay on his feet in the postoperative care unit.Body temperature, heart rate,blood pressure,SPO2 values will be recorded every fifteen minutes.He will be transferred from the postoperative care unit to the clinic with socks.will stay. After transferring to the bed,body temperature,heart rate, arterial blood pressure, SPO2 will be recorded every fifteen minutes for a total of 180minutes.Chills,chills and the total drainage amount for 24hours will be recorded in the same section.
Study NCT04914676 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cytarabine
Description: Subjects on this arm will prospectively receive consolidation therapy with cytarabine. Subjects will be treated with 1000 mg/m2 cytarabine intravenously every 12 hours on Days 1-3 of each consolidation cycle. Subjects will receive up to four consolidation cycles.
Study NCT04914676 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Cytarabine
Description: Subjects on this arm will have received consolidation therapy with cytarabine between 2/1/2017 and 2/1/2019. Subjects will have received 1000 mg/m2 cytarabine intravenously every 12 hours on days 1, 3, and 5 of each consolidation cycle and will have received up to 4 consolidation cycles.
Study NCT05992766 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Reformer Pilates
Description: Reformer Pilates exercises activates the lumbopelvic muscles and supports functional movement. Activated muscles support the spine and reduce the load on the spine by correcting the posture, helping the core muscles such as the abdomen and spine stay healthier by attaching them to a neutral pelvis Pilates consists of a sliding platform working with the help of a pulley system specific to the use, allowing the individual to apply certain resistances, and providing the opportunity to exercise sitting, standing, or lying down.
Study NCT05992766 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Hammock Yoga
Description: Hammock Yoga is performed with a silk hammock, which is an auxiliary equipment. The most distinctive characteristic that makes Hammock Yoga different from other exercises is the spine traction provided by the upside-down posture, and the smooth and shiny silk hammock allows strengthening exercises. The Hammock Yoga aims to reduce the load on the spine by upside-down postures that defy the laws of physics.
Study NCT05992766 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Traditional mat exercises
Description: The mat exercises help build core strength, stamina, and motor control of the abdominal and lumbar trunk musculature. The exercises focus on the re-education of a precise co-contraction pattern of local muscles of the spine. Also mat exercise increases the level of endorphins and the stimulation of mechanoreceptors, causing biomechanical stress to support healing in tissues.
Study NCT05533918 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Text-Messaging (TM)
Description: Participants in the TM condition will receive HIPAA-compliant bidirectional text messages. These texts will include a brief message alerting patients that they are eligible to receive a test kit and asking participants if they would like to receive a test kit. Participants who reply yes will receive an additional message with information about how to receive a test kit.
Study NCT05533918 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Patient Navigation (PN)
Description: Patient navigation from the Community Health Worker includes practical advice in addressing barriers to testing such as logistics, as well as fear, skepticism, and hesitancy.~There are two distinct different types of patient navigation, Request PN and No PN. Each person will be randomly assigned between the two types.
Study NCT04239027 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RTH258/Brolucizumab
Description: Brolucizumab is a new generation of anti-VEGF (vascular endothelial growth factor). All patients were treated with brolucizumab 6mg: 3 loading injections (at Screening/Baseline, Week 4 and Week 8), followed by maintenance treatment every 8 weeks (Q8W) or every 12 weeks (Q12W) depending on disease activity from Week 16/Week20 to Week 40/Week 44.~Brolucizumab was administered by an intravitreal (IVT) injection to the study. eye.
Study NCT05707754 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupivacaine
Description: Topically applied to sphenopalatine ganglion
Study NCT05707754 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: angiocatheter
Description: Introduced into nose to reach sphenopalatine ganglion nerve
Study NCT06343402 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BBO-8520
Description: Participants will receive assigned dose of BBO-8520 orally (PO), QD
Study NCT06343402 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Patients will receive IV pembrolizumab
Study NCT05467839 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: derma pen
Description: Derma pen is automatic and rechargeable device (vibrating frequency:6500-10000 r/m, vibration speed level 5, model: Ultima A6, company: Dr. Pen and country: Korea). With every case the needle should be replaced. Needle length is adjustable from 0.25mm to 2mm according to the treated areas. The pen is convenient in treating narrow areas such as the nose, around the eye and the mouth. The vibration speed of the pen can be controlled in 5 levels
Study NCT05888961 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Blood samples
Description: Fasting at the first session for hormonal measurements of leptin, insulin, acylated and non-acylated ghrelin, serotonin, albumin, protidemia and blood glucose.~Repeated at 6 and 12 months for follow-up
Study NCT05888961 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Blood samples
Description: Fasting at the first session for hormonal measurements of leptin, insulin, acylated and non-acylated ghrelin, serotonin, albumin, protidemia and blood glucose.~Repeated at 6 and 12 months for follow-up
Study NCT05888961 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Interviewing the subject and scales
Description: Collection of sociodemographic data, personal and family neurological history, treatments, MADRS depression scale and CDR autonomy scale.~Carried out at the 1st session
Study NCT05888961 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Interviewing the subject and scales
Description: Collection of sociodemographic data, personal and family neurological history, treatments, MADRS depression scale and CDR autonomy scale.~Carried out at the 1st session
Study NCT05985538 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Vaping prevention text messages
Description: Participants will receive text messages (2 daily, on average) about the harms of e-cigarette use and vaping for 28 days, with introductory messages sent on day 1 and concluding messages sent on day 28. Each vaping prevention text message will focus on one of six topics: nicotine addiction, monetary costs of vaping, chemical exposures from e-cigarette vapor, cosmetic effects of vaping, mental and physical use symptoms of vaping, and health impact on organs from vaping. Some text messages will ask participants for a reply (i.e., two-way messages).
Study NCT05985538 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Wellness behaviors text messages
Description: Participants will receive text messages (2 daily, on average) about general wellness topics, with introductory messages sent on day 1 and concluding messages sent on day 28. Each wellness text message will focus on one of six topics: sleep hygiene, safe driving, sun safety, study habits, nutrition, and exercise. This attention control condition is matched with the intervention condition in that participants will receive the same number of text messages over the same number of days, the same intervention structure (e.g., 6 topics), and the same number and types of two-way messages.
Study NCT05888961 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Neurocognitive evaluation
Description: cognitive complaint questionnaire (CCQ), taste, smell, MoCA and MMSE (if not performed in the previous 6 months) Carried out at the 1st session. Repeated at 6 and 12 months for follow-up.
Study NCT05888961 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Neurocognitive evaluation
Description: cognitive complaint questionnaire (CCQ), taste, smell, MoCA and MMSE (if not performed in the previous 6 months) Carried out at the 1st session. Repeated at 6 and 12 months for follow-up.
Study NCT05888961 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Taste tests
Description: Sweet and salty flavors at the 1st session and acid and umami flavors at the 2nd session. Repeated at 6 and 12 months for follow-up.~Placement of electrodes on the scalp, recording of gustatory evoked potentials, subjective gustatory evaluation by means of visual analogue scales rated from 0 to 10, identification and naming of each of the primary flavors
Study NCT05888961 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Taste tests
Description: Sweet and salty flavors at the 1st session and acid and umami flavors at the 2nd session. Repeated at 6 and 12 months for follow-up.~Placement of electrodes on the scalp, recording of gustatory evoked potentials, subjective gustatory evaluation by means of visual analogue scales rated from 0 to 10, identification and naming of each of the primary flavors
Study NCT05888961 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Computerized food preference questionnaires
Description: Performed at the 1st session on a tactile tablet. Repeated at 6 and 12 months for follow-up.
Study NCT05888961 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Computerized food preference questionnaires
Description: Performed at the 1st session on a tactile tablet. Repeated at 6 and 12 months for follow-up.
Study NCT05888961 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Nutritional status - body composition
Description: Measurement of anthropometric data, bioelectrical impedancemetry (measurement of fat mass, lean mass, water mass and bone mass in kg), measurement of blood pressure and heart rate Performed at the 2nd session Repeated at 6 and 12 months for follow-up.
Study NCT05888961 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nutritional status - body composition
Description: Measurement of anthropometric data, bioelectrical impedancemetry (measurement of fat mass, lean mass, water mass and bone mass in kg), measurement of blood pressure and heart rate Performed at the 2nd session Repeated at 6 and 12 months for follow-up.
Study NCT06371118 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Directly mailed self-sampling kit to collect a vaginal sample
Description: The HPV self-sampling test will be sent by post directly to the woman's address. If the woman does not return the sample within 20 days, she will be sent a SMS reminder.~The returned samples will be analysed. If high-risk HPV is present, women will be invited to be screened for cervical cancer in a clinical setting by their family doctors.~Self-samples in which high-risk HPV is present will also be subjected to HPV DNA methylation test. If an abnormal HPV DNA methylation is detected and the woman has not attended the screening in a clinical setting yet, she will be informed by her family doctor that a new test has indicated the need to attend a medical appointment.